Regulatory & Compliance
REACH, GHS, FDA and trade rules that affect sourcing and documentation.
FDA Proposed Rule: Increased Supply Chain Transparency for Fine Chemicals
The FDA’s latest proposal to modernize drug establishment registration marks a critical shift toward enhanced traceability, necessitating a review of upstream supply chain compliance for procurement managers.
Read · 6 min→US Chemical Manufacturing Security: Impact on Procurement
A two-year regulatory relief period for domestic chemical producers offers immediate supply stability but requires careful navigation for procurement and QA teams.
Read · 5 min→FDA Drug Establishment Registration: Supply Chain Transparency
New FDA proposals aim to modernise drug establishment registration, impacting how procurement and QA teams source and document fine chemicals and pharmaceutical intermediates.
Read · 6 min→REACH Restrictions Roadmap: Navigating 2026 Regulatory Shifts
The European Commission's updated REACH Restrictions Roadmap introduces critical clarity for chemical sourcing. We analyse the implications for procurement.
Read · 6 min→DEA Proposal on Phenethyl Halides: Impact on Chemical Sourcing
The DEA’s proposed List I classification for phenethyl halides necessitates immediate review of procurement workflows, compliance documentation, and supplier vetting processes.
Read · 5 min→Understanding the EPA UCMR 6 Proposal for Chemical Procurement
The EPA's proposed Sixth Unregulated Contaminant Monitoring Rule (UCMR 6) signals significant shifts for industrial PFAS monitoring. Here is what procurement teams and formulators must anticipate.
Read · 5 min→ECHA Regulatory Oversight: Strategic Implications for Chemical Sourcing
The European Union’s move to formalise ECHA’s administrative framework signals a new era of predictive regulation. Procurement managers must prepare for faster dossiers and heightened documentation standards.
Read · 5 min→Navigating Chemical Supply Chain Risks After the Chemours PFAS Settlement
A landmark environmental settlement with The Chemours Company reshapes the regulatory landscape, requiring procurement teams to reassess the long-term resilience and compliance costs of their fluorinated chemical supply chains.
Read · 5 min→PFAS Regulatory Settlement Impact on Chemical Sourcing
A landmark settlement involving the EPA and The Chemours Company sets a new precedent for environmental liability in the chemical industry, reshaping procurement and risk strategies.
Read · 5 min→PFAS Regulatory Compliance and Supply Chain Risk Management
A landmark settlement involving PFAS emissions marks a shift in environmental oversight. We examine the implications for chemical sourcing, compliance, and procurement resilience.
Read · 5 min→Operation TrialBlazer: FDA Initiatives and Chemical Sourcing Impact
The FDA's launch of Operation TrialBlazer signals a major shift in drug development timelines. We analyse the implications for procurement, CMC documentation, and intermediate sourcing.
Read · 5 min→PFAS Regulatory Settlement: Strategic Implications for Chemical Sourcing
A landmark settlement involving The Chemours Company sets a new precedent for environmental compliance, signalling significant shifts in risk management and supply chain transparency for procurement managers.
Read · 5 min→EPA and OSHA Hazardous Chemical Reporting Alignment
The EPA has updated EPCRA reporting to align with OSHA’s 2024 HCS, streamlining compliance for procurement and EHS departments. Learn what this means for your inventory documentation.
Read · 5 min→EPA TSCA Compliance: Navigating New Significant New Use Rules
The EPA's latest Significant New Use Rules under TSCA mandate strict 90-day notification windows for specific substances, impacting procurement and R&D pipelines.
Read · 5 min→Trifluoroacetic Acid Regulation: Sourcing and Compliance Impacts
ECHA’s classification of TFA as a reproductive toxicant signals a major shift for pharmaceutical and chemical supply chains. Here is how procurement and R&D teams should prepare.
Read · 5 min→ECHA Classification of Trifluoroacetic Acid as PMT/vPvM: Regulatory Impact
The European Chemicals Agency has classified TFA as a PMT/vPvM substance. Procurement and R&D teams must now prepare for stringent supply chain and regulatory shifts.
Read · 5 min→ECHA REACH and CLP Regulations Operation Report 2026 Analysis
An analysis of the 2026 ECHA report on REACH and CLP, detailing the implications for procurement teams and supply chain stability.
Read · 6 min→New EU REACH REACH Microplastic Regulations: A Sourcing Guide
The June 2026 update to EU REACH microplastic restrictions introduces critical changes for high-purity chemical sourcing. We analyse what these amendments mean for procurement, compliance, and pharmaceutical intermediate supply chains.
Read · 6 min→TSCA Compliance and Chemical Sourcing: Mitigating Regulatory Risk
Recent EPA enforcement actions highlight the necessity of rigorous supply chain transparency. We explore the implications for procurement and quality assurance teams.
Read · 5 min→EPA New Approach Methods: A Shift in Chemical Safety Standards
The EPA’s latest update to New Approach Methods (NAMs) signals a pivotal transition in chemical safety protocols, impacting regulatory compliance and procurement strategies.
Read · 5 min→
ECHA REACH Compliance: Navigating the 29th SVHC Update
The 29th update to the ECHA Candidate List introduces 247 new SVHCs. We examine the implications for electronic-grade chemical procurement and regulatory diligence.
Read · 5 min→